Conivaptan Hydrochloride and Ibritumomab Intravenous
Determining the interaction of Conivaptan Hydrochloride and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: conivaptan
Brand name: Vaprisol
Synonyms: Conivaptan
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Conivaptan Hydrochloride-Ibritumomab Tiuxetan
- Conivaptan Hydrochloride-Ibrutinib
- Conivaptan Hydrochloride-Ibrutinib Capsules
- Conivaptan Hydrochloride-Ibrutinib Tablets
- Conivaptan Hydrochloride-Ibu
- Conivaptan Hydrochloride-IBU Tablets
- Ibritumomab Intravenous-Conivaptan Intravenous
- Ibritumomab Intravenous-Conjugated estrogens
- Ibritumomab Intravenous-Conjugated estrogens and bazedoxifene
- Ibritumomab Intravenous-Conjugated estrogens and medroxyprogesterone
- Ibritumomab Intravenous-Conjugated estrogens and medroxyprogesterone Oral
- Ibritumomab Intravenous-Conjugated Estrogens Injection